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Abstract
The TOMM40‐APOE variants are known for their strong, antagonistic associations
with Alzheimer's disease and body weight. While a stronger role of the APOE than
TOMM40 variants in Alzheimer's disease was suggested, comparative contribution of
the TOMM40‐APOE variants in the regulation of body weight remains elusive. We
examined additive effects of rs2075650 and rs157580 TOMM40 variants and
rs429358 and rs7412 APOE variants coding the ε2/ε3/ε4 polymorphism on body
mass index (BMI) in age‐aggregated and age‐stratified cohort‐specific and cohort‐
pooled analysis of 27,863 Caucasians aged 20–100 years from seven longitudinal
studies. Minor alleles of rs2075650, rs429358, and rs7412 were individually associ-
ated with BMI (β = −1.29, p = 3.97 × 10−9; β = −1.38, p = 2.78 × 10−10; and
β = 0.58, p = 3.04 × 10−2, respectively). Conditional analysis with rs2075650 and
rs429358 identified independent BMI‐lowering associations for minor alleles
(β = −0.63, p = 3.99 × 10−2 and β = −0.94, p = 2.17 × 10−3, respectively). Polygenic
mega‐analysis identified additive effects of the rs2075650 and rs429358 heterozy-
gotes (β = −1.68, p = 3.00 × 10−9), and the strongest BMI‐lowering association for
the rs2075650 heterozygous and rs429358 minor allele homozygous carriers
(β = −4.11, p = 2.78 × 10−3). Conditional analysis with four polymorphisms identified
independent BMI‐lowering (rs2075650, rs157580, and rs429358) and BMI‐increasing
(rs7412) associations of heterozygous genotypes with BMI. Age‐stratified conditional
analysis revealed well‐powered support for a differential and independent association
of the rs429358 heterozygote with BMI in younger and older individuals, β = 0.58,
95% confidence interval (CI) = −1.18, 2.35, p = 5.18 × 10−1 for 3,068 individuals
aged ≤30 years and β = −4.28, CI = −5.65, −2.92, p = 7.71 × 10−10 for 6,052
individuals aged >80 years. TOMM40 and APOE variants are independently and
additively associated with BMI. The APOE ε4‐coding rs429358 polymorphism is
associated with BMI in older individuals but not in younger individuals.
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1 | INTRODUCTION
Studies report that deviation from the normal body weight is associ-
ated with cognitive decline and development of dementia and Alz-
heimer's disease (AD) (Emmerzaal, Kiliaan, & Gustafson, 2015).
Despite these results are challenged in Fitzpatrick et al. (2009), they
suggest that there might be common underlying biological mecha-
nisms involved in regulation of body weight and cognitive function
and/or AD pathology (Hinney et al., 2014). The relationship between
body weight and cognitive function is complex as it may vary with
age from a positive relationship between mid‐life obesity and AD to
a negative relationship in late life (Emmerzaal et al., 2015).
High throughput genotyping of large human samples provides an
opportunity for designing well‐powered studies to examine whether
the same genetic variants can be associated with body weight and
AD. The 19q13.3 genomic region harboring the APOE (apolipopro-
tein E) and TOMM40 (translocase of outer mitochondrial membrane
40 homolog) genes represents an opportunity for such an analysis as
it harbors pleiotropic variants conferring the strongest, well‐docu-
mented risk of AD and robust associations with BMI (body mass
index, kg/m2) (Guo et al., 2013; Roses et al., 2010). Indeed, this locus
harbors common APOE ε2/ε3/ε4 polymorphism, coded by rs429358
and rs7412 SNPs (single nucleotide polymorphisms). The APOE ε4
allele has been most consistently associated with AD in late life in
various populations (Raichlen & Alexander, 2014). Genome‐wide
association studies (GWAS) also report an AD‐increasing effect of
the rs2075650 (TOMM40) minor allele and AD‐decreasing effect of
the rs157580 (TOMM40) minor allele (Bao, Wang, & Mao, 2016;
Harold et al., 2009). The association of rs2075650 with AD is often
attributed (Yu et al., 2007) to linkage disequilibrium (LD) of this SNP
with rs429358, which encodes the APOE ε4 allele.
Large‐scale meta‐analysis of populations of European ancestry
reported a genome‐wide significant association of rs2075650 with
BMI, with the AD‐risk‐increasing (minor) allele associated with smaller
BMI (Guo et al., 2013). Whether the effect of this SNP should be
attributed to TOMM40 or APOE and, particularly, to the ε4 allele, has
not yet been addressed in large samples (Guo et al., 2013). Thus, we
performed cohort‐specific and cohort‐pooled analysis of 27,863 par-
ticipants from seven independent longitudinal studies to comprehen-
sively examine the associations of rs2075650 and rs157580 TOMM40
variants and rs429358 and rs7412 variants coding the APOE ε2/ε3/ε4
polymorphism with BMI in a Caucasian ancestry population sample as
well as in subpopulations of younger and older individuals.
2 | RESULTS
Data on 27,863 participants were obtained from seven longitudinal
cohort studies (ARIC, CHS, CARDIA, MESA, HRS, LLFS, and FHS)
(see Section 4). Baseline measurements of BMI, the number of longi-
tudinal measurements of BMI used in the analysis, and basic demo-
graphic information for the genotyped participants in each cohort
and the pooled sample are presented in Supporting Information
Table S1). Frequency distributions of genotypes for rs2075650,
rs157580, rs429358, rs7412, and APOE ε2/ε3/ε4 (coded by
rs429358 and rs7412, Supporting Information Table S2) polymor-
phisms are presented in Supporting Information Table S3. All poly-
morphisms were in Hardy–Weinberg equilibrium.
2.1 | LD structure
The largest LD (r2 = 49%) was observed between rs429358 and
rs2075650 (Figure 1) and was due to clustering of minor alleles of
these SNPs rather than their minor and major alleles (Supporting
Information Tables S4A and S4G). In contrast, LD between rs157580
and rs429358 was more modest (r2 = 8%) and due to depleted clus-
tering of minor alleles of these SNPs and preferable clustering of
their minor and major alleles (Supporting Information Tables S4B and
S4H). For the other SNPs pairs, LD measured by r2 was small.
Lewontin's D' varied from 25% to 100% (Figure 1).
2.2 | Univariate associations
In univariate analyses of single polymorphisms in the models, the
rs2075650 minor allele was associated with decreased BMI in each
cohort that resulted in a genome‐wide significant association in the
pooled sample of all cohorts (β = −1.29, p = 3.97 × 10−9; Figure 2).
The rs429358 minor allele, coding the APOE ε4 allele, showed the
same‐direction genome‐wide significant effect in this sample
(β = −1.38, p = 2.78 × 10−10). The rs7412 minor allele, coding the
APOE ε2 allele, showed the opposite‐direction nominally significant
effect in mega‐analysis (β = 0.58, p = 3.04 × 10−2). Mega‐analysis did
not show significant association for rs157580 (β = 0.15, p = 0.303).
The associations for the APOE ε2 allele, defined as the ε2ε2 or ε2ε3
genotypes, and the ε4 allele, defined as the ε3ε4 or ε4ε4 genotypes,
resembled those for rs7412 and rs429358, respectively, except the
association of ε2 allele with BMI was non‐significant (β = 0.46,
p = 0.136). Mega‐analysis of the effects of each APOE genotype com-
pared with the ε3ε3 genotype showed highly significant associations
for the ε3ε4 (β = −1.41, p = 7.68 × 10−8) and ε4ε4 (β = −2.41,
p = 3.32 × 10−3) genotypes and suggestive‐effect significance for the
ε2ε3 genotype (β = 0.55, p = 8.26 × 10−2) (Table 1, Model 1).
F IGURE 1 LD pattern of four SNPs in the TOMM40–APOE locus.
LD (%), r2 (a) and D' (b), is shown in the pooled sample of all cohorts
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2.3 | Independent associations of TOMM40 and
APOE polymorphisms with BMI
Despite moderate LD between rs2075650 and rs429358 (Figure 1),
bivariate mega‐analysis with these SNPs identified their independent
associations with BMI, although their effects became smaller (Table 1,
Model 2). Bivariate mega‐analysis with rs2075650 and rs7412
showed minor role of rs7412 in the association of rs2075650 with
BMI (Table 1, Model 3). Conditional mega‐analysis with rs2075650
and APOE genotypes (Table 1, Model 4) or ε2 and ε4 alleles (Table 1,
Model 5) resembled the results of the bivariate analysis. Association
of rs2075650 with BMI, independent of the ε4 allele, was confirmed
F IGURE 2 Genetic associations with BMI in each cohort and in the pooled sample of all cohorts (all). Associations of rs2075650 and
rs157580 polymorphisms are from additive genetic model with minor allele as an effect allele. Statistical models for APOE were fitted
considering the effect of the ε2 and ε4 alleles as compared with the ε3ε3 reference genotype. SE denotes standard error. Horizontal bars
indicate 95% confidence intervals
KULMINSKI ET AL. | 3 of 10
in the mega‐analysis of carriers of the ε3ε3 genotype only
(β = −1.01, p = 2.65 × 10−2; Supporting Information Table S5).
Rs157580 did not attenuate the association of rs2075650,
rs429358, rs7412, or ε2/ε3/ε4 polymorphisms with BMI (Supporting
Information Table S6). The effect of rs157580 remained non‐signifi-
cant but its direction changed aligning with the effect of the ε4 allele
in all models except that with rs7412 (Supporting Information
Table S6, Model 4).
Conditional mega‐analysis, with rs2075650, rs157580, rs429358,
and rs7412 in the model, showed that all heterozygotes were indepen-
dently associated with BMI (Table 2). Heterozygotes of rs2075650,
rs429358, and rs157580 showed BMI‐lowering associations, whereas
the rs7412 heterozygote (coding the APOE ε2ε3 and ε2ε4 genotypes)
showed BMI‐increasing association. Conditional mega‐analysis with
rs2075650, rs157580, and APOE genotypes did not show significant
effects for either the ε2ε3 (β = 0.53, p = 9.25 × 10−2) or ε2ε4
(β = −0.11, p = 8.86 × 10−1) genotypes alone (Supporting Information
Table S7) implying that examination of rs429358 and rs7412 SNPs
rather than the APOE genotypes can help in separating the effects of
the ε2 and ε4 alleles. The rs429358 minor allele homozygote (coding
the APOE ε4ε4 genotype) was significantly associated with smaller
BMI, whereas the BMI‐lowering association for the minor allele
homozygotes of the other SNPs did not attain significance (Table 2).
2.4 | Polygenic associations
Mega‐analysis of compound genotypes composed of rs2075650 and
rs429358 showed that the AA/Tc and Ag/TT genotypes were
independently associated with BMI at nominal (β = −0.94,
p = 3.63 × 10−2) and suggestive (β = −0.78, p = 8.67 × 10−2) levels
of significance, respectively (Figure 3 and Supporting Information
Table S8). The effect of the Ag/Tc heterozygous genotype was an
additive (linear) superposition of the effects of the rs2075650_Tc
and rs429358_Ag heterozygotes (β = −1.68, p = 3.00 × 10−9). Sub-
jects carrying the Ag/cc compound genotype had the strongest BMI‐
lowering association (β = −4.11, p = 2.78 × 10−3). This result is in
qualitative agreement with the result of mega‐analysis of polygenic
score composed of these SNPs, which identified the strongest effect
for carriers of three minor alleles (β = −2.72, p = 5.59 × 10−3; Sup-
porting Information Table S9, Model 1). However, specificity of the
analyses of the polygenic score was poorer compared with the anal-
yses of compound genotypes, as evidenced by smaller effect size in
the latter case. Polygenic score composed of rs2075650, rs429358,
and rs157580 SNPs supported significant BMI‐lowering associations
for carriers of three (β = −2.29, p = 3.19 × 10−8) and four
(β = −2.33, p = 3.08 × 10−2) minor alleles (Supporting Information
Table S9, Model 2).
2.5 | Independent associations of rs2075650,
rs157580, and APOE variants with BMI in younger
and older individuals
Given uncertainty in defining “younger” and “older” people, we used
varying cutoffs ranging from reproductive age (30 years) to the old-
est‐old age (90 years) in 5‐year increments. We selected 30 and
90 years as global cutoffs because the analysis in groups of even
TABLE 1 Univariate and multivariate associations of selected polymorphisms with BMI in a mega sample of 27,863 individuals from seven
longitudinal studies
Polymorphism
Model 1 Model 2 Model 3 Model 4 Model 5
β SE p‐value β SE p‐value β SE p‐value β SE p‐value β SE p‐value
rs2075650a −1.29 0.22 3.97E‐09 −0.63 0.31 3.99E‐02 −1.25 0.22 1.36E‐08 −0.61 0.31 4.71E‐02 −0.67 0.30 2.63E‐02
rs157580a 0.15 0.15 3.03E‐01
rs429358a −1.38 0.22 2.78E‐10 −0.94 0.31 2.17E‐03
rs7412a 0.58 0.27 3.04E‐02 0.41 0.27 1.30E‐01
ε2ε2b −1.23 1.30 3.45E‐01 −1.28 1.30 3.27E‐01
ε2ε3b 0.55 0.31 8.26E‐02 0.52 0.32 9.81E‐02
ε2ε4b −0.66 0.71 3.54E‐01 −0.27 0.74 7.20E‐01
ε3ε4b −1.41 0.26 7.68E‐08 −0.99 0.34 3.48E‐03
ε4ε4b −2.41 0.82 3.32E‐03 −1.56 0.92 9.26E‐02
ε2c 0.46 0.31 1.36E‐01 0.43 0.31 1.63E‐01
ε4c −1.48 0.26 6.50E‐09 −0.98 0.34 3.97E‐03
Notes. Model 1: Associations of rs2075650, rs157580, rs429358, rs7412, APOE genotypes, and APOE alleles separately. The APOE ε2 allele was defined
as the ε2ε2 or ε2ε3 genotypes. The APOE ε4 allele was defined as the ε3ε4 or ε4ε4 genotypes. The ε2/ε4 genotype was excluded from definition of the
ε2 or ε4 carrier status.
Model 2: Bivariate model of additive effects of rs2075650 and rs429358 SNPs.
Model 3: Bivariate model of additive effects of rs2075650 and rs7412 SNPs.
Model 4: Multivariate model of additive effects of rs2075650 and APOE genotypes.
Model 5: Multivariate model of additive effects of rs2075650 and APOE alleles.
aAdditive genetic model with minor allele as an effect allele. bGenotypic model for APOE with the ε3ε3 genotype as a reference. cAllelic model for APOE
with the ε3ε3 genotype as a reference.
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younger and older ages was not sufficiently powered. In conditional
analysis, with rs2075650, rs157580, rs429358, and rs7412 in the
model, there were no significant differences between the effect esti-
mates in younger and older carriers of the rs2075650 heterozygote
at any given cutoff, as evidenced by well‐overlapped confidence
intervals (CIs) (Figure 4a). Nevertheless, there was a trend for a
decreased magnitude of the effect size with age from β = −0.84,
p = 1.39 × 10−2 for individuals older than 30 years to β = −0.28,
p = 8.55 × 10−1 for individuals older than 90 years. The effects were
virtually age independent for carriers of the rs157580 heterozygote
(Supporting Information Table S10).
In contrast, we observed significant differences between the
associations of the rs429358 heterozygote with BMI in younger and
older individuals starting at age of about 60 years (i.e., β = −0.15,
CI = −0.99, 0.69, p = 7.32 × 10−1 for individuals aged 60 years and
younger and β = −1.69, CI = −2.46, −0.91, p = 1.94 × 10−5 for
those who were older than 60 years; Figure 4b). There was an
apparent trend for an increasing magnitude of the effect size for the
older heterozygous carriers of rs429358 until the age of about
80 years, independent of rs2075650, rs157580, and rs7412. For
example, for the rs429358 heterozygotes who were 30 years and
younger, the effect was in positive direction and non‐significant
(β = 0.58, CI = −1.18, 2.35, p = 5.18 × 10−1), whereas for those who
were older than 80 years it was in negative direction, large, and gen-
ome‐wide significant (β = −4.28, CI = −5.65, −2.92,
p = 7.71 × 10−10). For individuals aged 85 years and older, the effect
becomes smaller, although standard errors increase due to smaller
sample sizes. These trends were similar for carriers of the rs429358
minor allele homozygotes (coding the APOE ε4ε4 genotype),
although confidence intervals for most groups of older and younger
subjects overlapped (Supporting Information Table S10). We did not
observe significant differences between the effects in younger and
older carriers of either the rs7412 genotypes (Supporting Informa-
tion Table S10). The results were qualitatively the same in the mod-
els with the APOE genotypes and alleles.
3 | DISCUSSION
This study presents the results of the largest analysis so far of the
associations of TOMM40 (rs2075650 and rs157580) and APOE
(rs429358 and rs7412 coding the ε2/ε3/ε4 polymorphism) variants
with BMI in seven cohorts of participants ranging in age from early
reproductive age (about 20 years) to centenarians. These analyses
leveraged longitudinal information on BMI assessed at different ages
and addressed the impact of TOMM40 and APOE variants in the
age‐aggregated and age‐stratified samples of older and younger indi-
viduals defined using varying cutoffs ranging from 30 years (i.e., peo-
ple who were younger and older than 30 years at BMI assessment)
to 90 years.
Our age‐aggregated analysis shows that minor alleles of rs2075650
and rs429358 are individually associated with smaller BMI (β = −1.29,
p = 3.97 × 10−9 and β = −1.38, p = 2.78 × 10−10, respectively) and the
rs7412 minor allele is associated with larger BMI (β = 0.58,
p = 3.04 × 10−2). Rs157580 did not show significant individual associa-
tion with BMI. This analysis confirms BMI‐lowering association of the
rs2075650 minor allele, first reported in Guo et al. (2013).
Given modest LD between rs2075650 and rs429358 (r2 = 49%
in our sample), the effect of rs2075650 is often considered as a
proxy for that of the APOE ε4 allele. For example, studies of longev-
ity indicate that strong effect of rs2075650 is likely due to the
effect of the APOE isoforms (Murabito, Yuan, & Lunetta, 2012).
Studies of AD also indicate that TOMM40 variants are unlikely to
have a major effect on AD (Yu et al., 2007), although the role of
TOMM40‐APOE haplotypes in AD is also acknowledged (Jazwinski
et al., 2010; Lescai et al., 2011; Roses et al., 2010). The role of
TOMM40 and APOE variants in body fat remains, however, unclear
(Guo et al., 2013). Dissecting this role is important because overall
body fatness is considered as a modifiable mid‐life risk factor for
development of dementia and AD in late life whereas elevated BMI
in late life may have beneficial effect on these conditions (Emmerzaal
TABLE 2 Conditional associations with BMI in a mega sample of
27,863 individuals when all four SNPs are included in a genotypic
model
Polymorphism
Heterozygote Minor allele homozygote
β SE p‐value β SE p‐value
rs2075650 −0.83 0.34 1.35E‐02 −0.33 1.03 7.48E‐01
rs157580 −0.56 0.23 1.53E‐02 −0.19 0.33 5.65E‐01
rs429358 −0.90 0.34 7.61E‐03 −2.27 1.02 2.59E‐02
rs7412 0.57 0.29 4.81E‐02 −1.25 1.30 3.39E‐01
Note. Major allele homozygous genotype was the reference.
F IGURE 3 Associations of compound
genotypes composed of rs2075650 and
rs429358 SNPs with BMI. (a) Effect sizes β
and 95% confidence intervals for the most
frequent compound genotypes. (b) Effect
sizes β for all compound genotypes. Letters
denote rs2075650/rs429358 genotypes.
Upper‐ (lower‐) case letter denotes major
(minor) allele. Common AA/TT genotype
was the reference. Numbers 0, 1, and 2
code the number of minor alleles
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et al., 2015) while underweight may increase risk of progression to
AD in older subjects over time (Joo et al., 2018).
Our conditional analysis with rs2075650 and rs429358 identified
independent BMI‐lowering associations of their minor alleles,
although the effect sizes (βs) for both SNPs became substantially
smaller (β = −0.63, p = 3.99 × 10−2 and β = −0.94, p = 2.17 × 10−3,
respectively). Polygenic mega‐analysis of compound variants identi-
fied additive effects of heterozygotes of these two SNPs (β = −1.68,
p = 3.00 × 10−9) and the strongest BMI‐lowering risk for carriers of
the rs2075650 heterozygote and rs429358 minor allele homozygote
(i.e., ε4ε4), β = −4.11, p = 2.78 × 10−3. The latter effect implies that
carriers of these genotypes have 1.05 kg/m2 lower BMI compared
with carriers of the major allele homozygotes. Mega‐analysis of poly-
genic score indicated the largest BMI‐lowering risks of three minor
alleles of these SNPs, although it was smaller than that for com-
pound genotypes. Accordingly, the analysis of compound variants
was more useful in this study than that of polygenic score, con-
structed as sum of SNP‐unspecified minor alleles, because it identi-
fied specific genetic profile of people with strong predisposition to
lower BMI.
Previous studies reported that TOMM40‐APOE variants other
than rs2075650 may be involved in regulation of body fat (Lu
et al., 2016). Our conditional analysis, with rs2075650, rs157580,
rs429358, and rs7412 in the model, identified independent associ-
ations of all heterozygous genotypes (despite the lack of significant
individual effect of rs157580) with BMI. The rs2075650,
rs157580, and rs429358 heterozygotes were independently associ-
ated with lower BMI. Mega‐analysis of polygenic score composed
of the rs2075650, rs429358, and rs157580 SNPs identified the
largest BMI‐lowering risks of virtually the same size for carriers of
three (β = −2.29, p = 3.19 × 10−8) and four (β = −2.33,
p = 3.08 × 10−2) minor alleles, although these effects were about
half of the strongest effect size for the rs2075650/rs429358 com-
pound variants (see above). Consistent with previous studies (Teje-
dor, Garcia‐Sobreviela, Ledesma, & Arbones‐Mainar, 2014; Volcik
et al., 2006), the rs7412 heterozygote was associated with higher
BMI in the current analysis.
TOMM40 encodes a protein localized in the outer membrane of
the mitochondria, which is a part of a complex for mitochondrial
protein import (Endo & Yamano, 2010). Mitochondria are a major
player in ATP production, maintaining energy balance, and disposal
of reactive oxygen species. Excessive energy can disrupt mitochon-
drial function that affects lipid and glucose metabolism (Bournat &
Brown, 2010). Disruption of mitochondrial transport, followed by
mitochondrial dysfunction, might be hypothesized as a plausible
mechanism for TOMM40 in regulation of adipocyte function and
overall body fatness (Gómez‐Serrano et al., 2017). Studies suggest
that APOE, a key protein in lipid metabolism, plays a role in adipo-
cyte function. APOE has been implicated in the development of
diet‐induced obesity (Elosua et al., 2003; Feitosa et al., 2006;
Kypreos et al., 2009). The APOE isoforms can be involved in regu-
lation of body fatness through differences in clearance of dietary
fat (Kolovou, Damaskos, Anagnostopoulou, & Cokkinos, 2009; Koo-
pal, van derGraaf, Asselbergs, Westerink, & Visseren, 2015). Mice
studies suggest differential role of the APOE isoforms in digesting
dietary energy (Arbones‐Mainar, Johnson, Altenburg, & Maeda,
2008; Huebbe et al., 2015; Kuhel et al., 2013). The mechanism of
influence of APOE on body fat traits might be through modulation
on triglyceride content of adipocytes (Kypreos et al., 2009; Li &
Liu, 2014).
Our age‐stratified conditional analysis with rs2075650,
rs157580, rs429358, and rs7412 in the model revealed well‐pow-
ered support for a differential association of the APOE ε4‐coding
rs429358 variant with BMI in younger and older individuals, inde-
pendent of rs2075650, rs157580, and rs7412. The effect of the
rs429358 heterozygous genotype is most pronounced in individuals
aged 60–80 years. No significant effect of this variant was observed
in younger people in their early reproductive life (e.g., β = 0.58, CI =
−1.18, 2.35, p = 5.18 × 10−1 for people aged ≤30 years, N = 3,068)
but it was strong and robust in older people (e.g., β = −4.28, CI =
−5.65, −2.92, p = 7.71 × 10−10 for people aged >80 years,
N = 6,052). Few previous studies examining associations of the
APOE isoforms with body fat traits reported associations of the ε4
allele with decreased obesity in less‐fitted children (Ellis et al., 2011)
and non‐significant trend in mid‐aged adults (Volcik et al., 2006). Our
previous study identified lower BMI in older ε4 allele carriers com-
pared with the non‐carriers in the FHS original cohort at ages
>65 years (Yashin et al., 2013). The differential role of the APOE ε4
F IGURE 4 Independent associations of genetic variants with BMI in younger and older individuals. Cutoff shown on the x‐axis defines
younger (red dots) and older (blue diamonds) individuals. Effect sizes β and 95% confidence intervals for (a) rs2075650_Ag and (b)
rs429358_Tc heterozygotes in conditional analysis with rs2075650, rs157580, rs429358, and rs7412 in the model. Upper‐ (lower‐) case letter
denotes major (minor) allele. Major allele homozygote was the reference. Numerical estimates are given in Supporting Information Table S10
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allele in BMI in younger and older individuals is consistent with dif-
ferential role of the ε4 allele in total cholesterol with age (Kulminski
et al., 2013) and with change of frequency of this allele with birth
years (Nygaard et al., 2014). This is also in line with age‐specific
associations of the ε4 allele with survival (Jacobsen et al., 2010; Tan
et al., 2013), although this effect can be sex‐specific (Joshi et al.,
2016; Kulminski et al., 2014). No significant age‐dependent associa-
tions of the TOMM40 SNPs and the APOE ε2 allele with BMI, that is
difference in younger and older individuals, were identified.
Although, there was a non‐significant trend on decreased magnitude
of the effect for the rs2075650 older heterozygotes.
Our results on the differential role of the APOE ε4 allele in BMI
in younger and older individuals contribute to better understanding
of genetic architecture underlying differential role of elevated mid‐
and late‐life BMI in risks of AD and dementia (Emmerzaal et al.,
2015). They suggest that the ε4 allele may provide late‐life‐specific
contribution to increased risk of AD through the mechanism of regu-
lation of body fat, as discussed above, that is consistent with
increasing risk of AD with age in general population (Akushevich,
Kravchenko, Ukraintseva, Arbeev, & Yashin, 2012) and higher risk
for underweight subjects to develop AD in old age (Joo et al., 2018).
These results warrant comprehensive longitudinal analysis of
dynamic connections between body fat metabolism and progression
to AD over the individuals’ life course. Such analysis is necessary to
examine genetic predisposition to complex interplay of changes in
the body composition with age, aging process, and time trends in
obesity and incidence of AD.
The results for the APOE ε2/ε3/ε4 polymorphism resembled those
for rs429358 and rs7412 SNPs. Examination of rs7412 was, how-
ever, more beneficial in this study because of the ability to better
handle the associations for the ε2 and ε4 alleles.
Despite rigor of this study, there are potential limitations. First,
although this is the largest study of additive effects of the
TOMM40‐APOE locus SNPs to date, more accurate determination of
associations for minor allele homozygous carriers and the associa-
tions at extreme ages requires larger samples. Second, we did not
investigate the effect of secular trends in BMI, compositional
changes in the studied cohorts during follow‐up, and potential role
of behavioral factors.
Thus, in addition to confirmation of the BMI‐lowering association
of the rs2075650 minor allele, this study provided three major
insights. First, it identified that despite modest LD, rs2075650 and
rs429358 SNPs were independently associated with lower levels of
BMI. Second, the associations of these SNPs were of additive (i.e.,
complementary) nature. Third, this study revealed that the APOE ε4‐
coding rs429358 SNP was associated with BMI in older individuals
but not in younger individuals, independently of rs2075650,
rs157580, and rs7412 SNPs. These results signify independent and
additive roles of the APOE and TOMM40 genes in body fat regula-
tion that indicates different (i.e., the APOE‐ and TOMM40‐related)
mechanisms of such regulation in this locus. They also signify poten-
tial age‐sensitivity of the APOE‐related mechanism as the relationship
of the APOE ε4 allele to BMI differs in younger and older subjects.
4 | EXPERIMENTAL PROCEDURES
4.1 | Accession numbers
This manuscript was prepared using a limited access datasets
obtained though dbGaP. The dbGaP accession numbers are as fol-
lows: phs000007.v22.p8 (FHS), phs000280.v2.p1 (ARIC),
phs000209.v12.p3 (MESA), phs000287.v3.p1 (CHS),
phs000285.v3.p2 (CARDIA), and phs000428.v1.p1 (HRS). Phenotypic
HRS data are available publicly and through restricted access from
the University of Michigan https://hrsonline.isr.umich.edu/index.php?
p = data.
4.2 | Study cohorts
Data were obtained from seven longitudinal studies from the
Atherosclerosis Risk in Communities (ARIC) study (Investigators,
1989), Cardiovascular Health Study (CHS) (Fried et al., 1991), Coron-
ary Artery Risk Development in Young Adults (CARDIA) study (Fried-
man et al., 1988), Multi‐Ethnic Study of Atherosclerosis (MESA)
(Blind et al., 2002), Health and Retirement Study (HRS) (Juster &
Suzman, 1995), Long Life Family Study (LLFS) (Sebastiani et al.,
2009), and Framingham Heart Study (FHS) (Splansky et al., 2007)
cohorts for individuals of Caucasian ancestry. The FHS included
three cohorts comprising parental (FHS_C1), offspring (FHS_C2), and
grandchildren (FHS_C3) generations. Basic demographic information
for the genotyped participants in the selected studies is provided in
Supporting Information Table S1.
4.3 | Genotypes
Rs2075650 and rs157580 SNPs from TOMM40 gene were available
from Affymetrix (1 M SNPs) chip in the ARIC and MESA, Illumina
CVDSNP55v1_A (50 K SNPs) chip in the CARDIA, CHS, and FHS,
and Illumina HumanOmni 2.5 Quad chip (2.5 M SNPs) in the HRS
and LLFS. Two SNPs coding the APOE ε2/ε3/ε4 polymorphism (ε2ε2,
ε2ε3, ε2ε4, ε3ε3, ε3ε4, ε4ε4), rs7412 and rs429358, were available
from Illumina Hiseq 2000 in ARIC and MESA, and the Taqman array
in the LLFS. APOE in CARDIA, CHS, FHS_C1, and FHS_C2 were
genotyped directly. Rs7412 and rs429358 for participants of the
HRS and FHS_C3 were imputed (IMPUTE2) according to the 1000
Genomes Project Phase I integrated variant set release (SHAPEIT2) in
the NCBI build 37 (hg19) coordinate with high accuracy (info >0.9).
The rs7412 and rs429358 minor alleles code the APOE ε2 and
ε4 alleles, respectively (Supporting Information Table S2). This rela-
tionship is useful to unambiguously assign the APOE ε2ε4 genotype
coded by the rs7412 and rs429358 heterozygotes. For comparison,
we also defined the ε2 allele as ε2/ε2 or ε2/ε3 genotypes and the ε4
allele as ε3/ε4 or ε4/ε4 genotype excluding the ε2/ε4 genotype from
definition of the ε2 or ε4 carrier status. Genotyping information for
all polymorphisms is presented in Supporting Information Table S3.
Missing information on SNPs was excluded to have balanced
samples with the same number of subjects for each SNP. Polygenic
scores were defined as unweighted counts of minor alleles.
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4.4 | Analysis
Measurements of BMI were natural‐log‐transformed to offset poten-
tial bias due to skewness of their frequency distributions and multi-
plied by 100 for better resolution. BMI was measured multiple times
during follow‐up of the same individuals in most cohorts (Supporting
Information Table S1). We used all available measurements. Informa-
tion on longitudinal measurements has multiple advantages including
potential gain in statistical power in the analyses (Shi, Rice, Gu, &
Rao, 2009). The analyses were performed in each cohort separately
and the mega sample of all cohorts combined. To correct for
repeated‐measurements (all cohorts) and familial (FHS and LLFS) cor-
relations, we used the linear mixed effects model (lme4 package in
R). We evaluated the associations for SNPs given the measurements
of BMI for individuals of a given age at each examination with avail-
able measurements. Because of longitudinal follow‐up, the same indi-
viduals were used in age‐stratified analyses in “old” and/or “young”
group depending on his/her age at BMI assessment. The models
were adjusted for sex and birth cohorts. Potential inter‐study differ-
ences were handled by using mixed effects for studies. The models
were not adjusted for principal components to control for population
stratification in these Caucasian populations because of their trivial
effects in these analyses.
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